1. Home
  2. SPT vs AMPH Comparison

SPT vs AMPH Comparison

Compare SPT & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPT
  • AMPH
  • Stock Information
  • Founded
  • SPT 2010
  • AMPH 1996
  • Country
  • SPT United States
  • AMPH United States
  • Employees
  • SPT N/A
  • AMPH N/A
  • Industry
  • SPT Computer Software: Prepackaged Software
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPT Technology
  • AMPH Health Care
  • Exchange
  • SPT Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • SPT 1.1B
  • AMPH 1.1B
  • IPO Year
  • SPT 2019
  • AMPH 2014
  • Fundamental
  • Price
  • SPT $20.77
  • AMPH $23.58
  • Analyst Decision
  • SPT Buy
  • AMPH Hold
  • Analyst Count
  • SPT 13
  • AMPH 5
  • Target Price
  • SPT $31.69
  • AMPH $38.00
  • AVG Volume (30 Days)
  • SPT 608.6K
  • AMPH 483.6K
  • Earning Date
  • SPT 07-31-2025
  • AMPH 08-06-2025
  • Dividend Yield
  • SPT N/A
  • AMPH N/A
  • EPS Growth
  • SPT N/A
  • AMPH N/A
  • EPS
  • SPT N/A
  • AMPH 2.77
  • Revenue
  • SPT $418,413,000.00
  • AMPH $730,659,000.00
  • Revenue This Year
  • SPT $12.32
  • AMPH $0.67
  • Revenue Next Year
  • SPT $11.90
  • AMPH $5.18
  • P/E Ratio
  • SPT N/A
  • AMPH $8.53
  • Revenue Growth
  • SPT 17.79
  • AMPH 8.05
  • 52 Week Low
  • SPT $18.52
  • AMPH $22.64
  • 52 Week High
  • SPT $39.75
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • SPT 47.22
  • AMPH 39.85
  • Support Level
  • SPT $19.88
  • AMPH $22.81
  • Resistance Level
  • SPT $21.63
  • AMPH $24.52
  • Average True Range (ATR)
  • SPT 0.65
  • AMPH 0.73
  • MACD
  • SPT 0.08
  • AMPH -0.25
  • Stochastic Oscillator
  • SPT 62.77
  • AMPH 20.87

About SPT Sprout Social Inc

Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: